LEXINGTON, Mass.--(BUSINESS WIRE)--Imprivata® (NYSE: IMPR), the healthcare IT security company, today announced expanded capabilities for Imprivata Confirm ID, a comprehensive user identity and two-factor authentication platform for the healthcare enterprise. Imprivata Confirm ID® provides hospitals with a single, centralized platform which offers secure and convenient strong authentication for electronic prescribing of controlled substances (EPCS), remote access, medical device access, and other critical clinical workflows.

Healthcare is in the midst of a cyber security war with 81 percent of healthcare organizations reporting they have been compromised by a cyber-attack, such as phishing, in the past two years, and only half believing they are adequately prepared for future attacks, according to a 2015 KPMG survey. The U.S. Department of Health and Human Services documented that hackers accessed more than 110 million patient health records in 56 major cybersecurity attacks in 2015. Imprivata Confirm ID enables fast, secure authentication to help safeguard healthcare enterprise workflows against hacking, creating a secure, auditable chain of trust, wherever, whenever, and however users interact with patient records, hospital financial data, and other sensitive information.

“As healthcare goes digital, critical clinical workflows are using simple, sometimes generic user names and passwords to provide access, making patient information easily vulnerable to hacking,” said Omar Hussain, president and CEO of Imprivata. “Imprivata’s commitment to our customers is to provide innovative authentication solutions that are seamlessly integrated into the care delivery process. I’m excited that we are building on the phenomenal success we saw with Imprivata Confirm ID in its first year for EPCS by expanding the platform to medical devices and remote access. Our medical device partnership with Capsule is the first of many to show how we can enable our customers to have one user experience for all of their strong authentication needs.”
With the Capsule SmartLinx Neuron 2 mobile clinical computer, Imprivata Confirm ID now facilitates strong authentication for medical devices to optimize how organizations capture, harness, and unlock the power of patient data. Imprivata will showcase this new integration at HIMSS 2016 (booth #3043). Imprivata Confirm ID also safeguards patient health information and allows hospitals to meet regulatory compliance requirements by improving visibility into user interactions with patient information on medical devices.

More HCB News